Joel D'Silva
Joel D'Silva
Unknown affiliation
Verified email at telenet.be
Title
Cited by
Cited by
Year
Taking temperature—A review of European Union regulation in nanomedicine
G Van Calster, J D'Silva
European Journal of Health Law 16 (3), 249-269, 2009
282009
Knowledge transfer from citizens’ panels to regulatory bodies in the domain of nano-enabled medical applications
J Evers, J D'Silva
Innovation–the European journal of social science research 22 (1), 125-142, 2009
182009
To Label or Not to Label-It's More Than a Nano-Sized Question
J D'Silva, DM Bowman
Eur. J. Risk Reg. 1, 420, 2010
172010
Pools, thickets and open source nanotechnology
J D'Silva
European intellectual property review 31 (6), 300-306, 2009
172009
Defining nanomaterials for the purpose of regulation within the European Union
D Bowman, J D'Silva, G Van Calster
European Journal of Risk Regulation, 115-122, 2010
152010
A game with rules in the making–how the high probability of waiting games in nanomedicine is being mitigated through distributed regulation and responsible innovation
J d'Silva, DKR Robinson, C Shelley-Egan
Technology analysis & strategic management 24 (6), 583-602, 2012
142012
Regulating nanomedicine: a European perspective
J D’Silva, G Van Calster
Nature Precedings, 1-1, 2008
102008
The Status of Consumers in European Water Regulation, Environmental Law and Consumer Protection
H Van Rijswick
Revue europeťnne de droit de la consommation 1, 115-148, 2011
92011
Nanotechnology: development, risk and regulation
J D’Silva
Paper for the British and Irish Law, Education and Technology Association†…, 2007
82007
What's in a Name-Defining a Nano-material for Regulatory Purposes in Europe
J D'Silva
Eur. J. Risk Reg. 2, 85, 2011
72011
For me to know and you to find out? Participatory mechanisms, the Aarhus Convention and new technologies
J D'Silva, G Van Calster
Studies in Ethics, Law, and Technology 4 (2), 2010
62010
Protecting consumers or failing them? The regulation of nanotechnologies in the EU
G Van Calster, DM Bowman, J D'Silva
European Journal of Consumer Law 1, 85-113, 2011
42011
The regulation of nanomedicine
J D’Silva, D Bowman
Nanomedicine in health and disease, 20-42, 2011
32011
Gambling regulation and risk
JP Vileneuve
Eur. J. Risk Reg. 1, 415, 2010
32010
Why the elephant in the room appears to be more than a nano-sized challenge
J D'Silva, DM Bowman
European Journal of Law and Technology 2 (3), 2011
22011
Regulatory Aspects of Nanomedicine in Europe
J D'Silva
Pan Stanford Publishing, Singapore, 2012
12012
The ‘wicked’problem of regulating nanotechnologies: Local and global challenges
DM BOWMAN, J D’SILVA
ENGAGEMENTS, 139, 2011
12011
Intellectual Property and Regulatory Issues at the Nanoscale
J D'Silva
SIZE MATTERS-ETHICAL, LEGAL AND SOCIAL ASPECTS OF NANOBIOTECHNOLOGY AND NANO†…, 2008
12008
Scientists and the Regulation of Risk: Standardising Control
J D'Silva
SCIENCE AND PUBLIC POLICY 40 (5), 701-703, 2013
2013
Standards, Risk and the Scientist
J D'Silva
Science and Public Policy 40 (5), 701-703, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20